Volume 28, Issue 7 e14879
CASE REPORT

Utilization of Hepatitis C Virus-Infected Donor Hearts in Two Children and Two Young Adults: Initial Experience at a Pediatric Transplant Center

Lauren E. Kushner

Lauren E. Kushner

Division of Pediatric Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, California, USA

Search for more papers by this author
Lauren Puckett

Lauren Puckett

Department of Pharmacy, Lucile Packard Children's Hospital at Stanford, California, USA

Search for more papers by this author
Joanne Lee

Joanne Lee

Department of Pharmacy, Lucile Packard Children's Hospital at Stanford, California, USA

Search for more papers by this author
Hayley A. Gans

Hayley A. Gans

Division of Pediatric Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, California, USA

Search for more papers by this author
Sruti Nadimpalli

Sruti Nadimpalli

Division of Pediatric Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, California, USA

Search for more papers by this author
Sharon Chen

Sharon Chen

Division of Pediatric Cardiology, Department of Pediatrics, Stanford University School of Medicine, California, USA

Search for more papers by this author
Michael Ma

Michael Ma

Division of Pediatric Cardiac Surgery, Department of Cardiothoracic Surgery, Stanford University School of Medicine, California, USA

Search for more papers by this author
Sharon F. Chen

Sharon F. Chen

Division of Pediatric Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, California, USA

Search for more papers by this author
Elizabeth L. Profita

Corresponding Author

Elizabeth L. Profita

Division of Pediatric Cardiology, Department of Pediatrics, Stanford University School of Medicine, California, USA

Correspondence:

Elizabeth L. Profita ([email protected])

Search for more papers by this author
First published: 27 October 2024

Funding: The authors received no specific funding for this work.

Elizabeth L. Profita and Sharon F. Chen have contributed equally as co-senior authors.

ABSTRACT

Background

Although adult transplant centers are successfully transplanting organs from hepatitis C virus (HCV)-infected donors with detectable viral load by nucleic acid testing (NAT+) into HCV-negative recipients, this practice has not yet been adopted widely by the pediatric heart transplant community.

Methods

We present a case series of four patients who received heart transplants from HCV NAT+ donors at a pediatric transplant center, including two pediatric patients < 18 years of age.

Results

All recipients tolerated a 12-week course of glecaprevir/pibrentasvir and achieved a sustained virologic response with no HCV or liver complications with over 1 year of follow-up (range 1.4–2.5 years). All four have had good post-heart transplant outcomes with normal graft function and good functional status without rejection or cardiac allograft vasculopathy at time of last follow-up.

Conclusions

This case series details the successful multidisciplinary implementation of a protocol to accept cardiac allografts from HCV NAT+ donors for transplantation into HCV negative recipients at our pediatric transplant center. With the limited donor pool in pediatrics and the morbidity associated with prolonged durations on the transplant waitlist, pediatric centers should consider utilizing organs from HCV NAT+ donors to broaden the donor pool. Future work should evaluate other organs beyond heart and optimal timing and duration of direct acting antiviral therapy.

Conflicts of Interest

The authors declare no conflicts of interest.

Data Availability Statement

The relevant data supporting the findings are available within the article. Additional de-identified information may be available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.